April 5-6, 2021 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is in development and subject to change
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.
In this digital age, making smart decisions based on copious amounts of rapidly amassed data from various sources is made possible by innovative techniques like machine learning (ML) and artificial intelligence (AI) algorithms. While this provides new opportunities for drug development and precision medicine, it also reveals ethical issues surrounding privacy and data sharing. Interpreting data demonstrates an additional challenge. Data must be presented in the patient’s terms and requires a well-defined patient context to be relevant. The goal of this meeting is to discuss emerging technology and the opportunities it provides.
Promising uses for AI/ML include drug discovery or repurposing, analyzing data from imaging and genomics and using digital biomarkers. Developing new drugs and techniques for precision medicine can be done with real-world data and decentralized trials. This meeting will draw interest from many fields and attendees will have the opportunity to consider challenges and potential solutions in data sharing, ethical considerations and patient relevance. The joint meeting, Digital Paths to Improve Human Health, will feature complimentary themes.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
‣ For Short Talk Consideration: March 8, 2021
‣ For Poster Booth: March 22, 2021
ePoster / SciTalk Submission: March 25, 2021
Financial Aid Application: March 22, 2021
*Abstract submission is required in order to submit an ePoster and/or Scitalk
Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.
Find out more about financial aid opportunities here!
Showcase your work to global audiences on the eSymposia platform!
Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration
ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:
To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.
Harvard University, USA
Koneksa Health, USA
Food and Drug Administration, USA
Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.